Founded in December 2021, Averoa’s goal is to build, advance and commercialise a strong pipeline of products to meet significant unmet medical needs of patients with kidney or metabolic diseases.
With a patient-centered approach, our mission is to offer patients comprehensive care of their renal diseases, based on effective therapeutic options supported by accurate diagnosis and advanced prognosis tools.
Averoa dedicates its research programs to develop alternative treatment for patients suffering from renal diseases but also developing reliable biomarkers or tools to facilitate the diagnosis and assess treatment outcomes to improve the overall management of a patient
President & CEO - Medical Director
Chief Financial Officer
Chief Operating Officer
Regulatory Affairs Manager
Business Development Director
Pharmaceutical Development Manager
Clinical-Regulatory Advisor
Identify and develop treatments where science can be applied in new ways of treating diseases with high medical needs.
Value-based health care is about putting the patient at the center to produce the best outcomes.
Develop efficient drugs for patients in a smart and quick way.
Science has become a team activity. We recognize its complexity and help innovative drugs reach their next step of development
